Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study

BACKGROUND: To assess the safety and efficacy of long-term administration of guanfacine extended-release (GXR) in adults with attention-deficit/hyperactivity disorder (ADHD). METHODS: In this open-label, long-term, phase 3 extension study in Japan, 150 patients transitioned from a double-blind trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwanami, Akira, Saito, Kazuhiko, Fujiwara, Masakazu, Okutsu, Daiki, Ichikawa, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531113/
https://www.ncbi.nlm.nih.gov/pubmed/33008345
http://dx.doi.org/10.1186/s12888-020-02867-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531113/
https://www.ncbi.nlm.nih.gov/pubmed/33008345
http://dx.doi.org/10.1186/s12888-020-02867-8

Ejemplares similares